An overview of chitosan and its application in infectious diseases.
Qingye MengYing SunHailin CongHao HuFu-Jian XuPublished in: Drug delivery and translational research (2021)
Infectious diseases, such as the coronavirus disease-19, SARS virus, Ebola virus, and AIDS, threaten the health of human beings globally. New viruses, drug-resistant bacteria, and fungi continue to challenge the human efficacious drug bank. Researchers have developed a variety of new antiviral and antibacterial drugs in response to the infectious disease crisis. Meanwhile, the development of functional materials has also improved therapeutic outcomes. As a natural material, chitosan possesses good biocompatibility, bioactivity, and biosafety. It has been proven that the cooperation between chitosan and traditional medicine greatly improves the ability of anti-infection. This review summarized the application and design considerations of chitosan-composed systems for the treatment of infectious diseases, looking forward to providing the idea of infectious disease therapy.
Keyphrases
- infectious diseases
- drug resistant
- drug delivery
- wound healing
- endothelial cells
- coronavirus disease
- public health
- hyaluronic acid
- multidrug resistant
- healthcare
- induced pluripotent stem cells
- acinetobacter baumannii
- pluripotent stem cells
- mental health
- type diabetes
- emergency department
- skeletal muscle
- sars cov
- adipose tissue
- combination therapy
- mesenchymal stem cells
- health promotion
- weight loss
- cell therapy
- drug induced
- replacement therapy
- respiratory syndrome coronavirus
- smoking cessation